Protein biomarkers for radiation injury and testing of medical countermeasure efficacy: promises, pitfalls, and future directions

References

• Gale RP, Armitage JO, Hashmi SK. Emergency response to radiological and nuclear accidents and incidents. Br J Haematol. 2021;192(6):968–972. doi: 10.1111/bjh.16138
   PubMed Web of Science ®Google Scholar
• Gale RP, Baranov A. If the unlikely becomes likely: medical response to nuclear accidents. Bull At Sci. 2011;67(2):10–18. doi: 10.1177/0096340211399849
   Web of Science ®Google Scholar
• Gusev IA, Guskova AK, Mettler FA. Medical management of radiation accidents. Boca Raton (FL): CRC Press; 2001.
   Google Scholar
• Goans RE, Holloway EC, Berger ME, et al. Early dose assessment following severe radiation accidents. Health Phys. 1997;72:513–518. doi: 10.1097/00004032-199704000-00001
   PubMed Web of Science ®Google Scholar
• Gorin NC, Fliedner TM, Gourmelon P, et al. Consensus conference on European preparedness for haematological and other medical management of mass radiation accidents. Ann Hematol. 2006;85:671–679. doi: 10.1007/s00277-006-0153-x
   PubMed Web of Science ®Google Scholar
• Ohnishi T. The disaster at Japan’s Fukushima-Daiichi nuclear power plant after the March 11, 2011 earthquake and tsunami, and the resulting spread of radioisotope contamination. Radiat Res. 2012;177:1–14. doi: 10.1667/RR2830.1
   PubMed Web of Science ®Google Scholar
• Dainiak N, Waselenko JK, Armitage JO, et al. The hematologist and radiation casualties. Hematol Am Soc Hematol Educ Prog. 2003;2003:473–496. doi: 10.1182/asheducation-2003.1.473
   Google Scholar
• Waselenko JK, MacVittie TJ, Blakely WF, et al. Medical management of the acute radiation syndrome: recommendations of the Strategic National Stockpile radiation working group. Ann Intern Med. 2004;140:1037–1051. doi: 10.7326/0003-4819-140-12-200406150-00015
   PubMed Web of Science ®Google Scholar
• Jargin SV. Chernobyl-related cancer and precancerous lesions: incidence increase vs. late diagnostics. Dose Resp. 2014;12:404–414. doi: 10.2203/dose-response.13-039.Jargin
   PubMed Web of Science ®Google Scholar
• Williams JP, McBride WH. After the bomb drops: a new look at radiation-induced multiple organ dysfunction syndrome (MODS). Int J Radiat Biol. 2011;87(8):851–868. doi: 10.3109/09553002.2011.560996
   PubMed Web of Science ®Google Scholar
• Ozasa K, Cullings HM, Ohishi W, et al. Epidemiological studies of atomic bomb radiation at the radiation effects research foundation. Int J Radiat Biol. 2019;95(7):879–891. doi: 10.1080/09553002.2019.1569778
   PubMed Web of Science ®Google Scholar
• Singh VK, Newman VL, Romaine PL, et al. Use of biomarkers for assessing radiation injury and efficacy of countermeasures. Expert Rev Mol Diagn. 2016;16:65–81. doi: 10.1586/14737159.2016.1121102
   PubMed Web of Science ®Google Scholar
• Singh VK, Simas M, Pollard H. Biomarkers for acute radiation syndrome: challenges for developing radiation countermeasures following animal rule. Expert Rev Mol Diagn. 2018;18(11):921–924. doi: 10.1080/14737159.2018.1533404
   PubMed Web of Science ®Google Scholar
• Dainiak N. Hematologic consequences of exposure to ionizing radiation. Exp Hematol. 2002;30(6):513–528. doi: 10.1016/S0301-472X(02)00802-0
   PubMed Web of Science ®Google Scholar
• Dainiak N. Rationale and recommendations for treatment of radiation injury with cytokines. Health Phys. 2010;98(6):838–842. doi: 10.1097/HP.0b013e3181b3fce5
   PubMed Web of Science ®Google Scholar
• U.S. Food and Drug Administration. Guidance document: product development under the animal Rule. 2015 [cited 2022 Oct 20]. Available from: http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm399217.pdf
   Google Scholar
• Deutsch EW, Omenn GS, Sun Z, et al. Advances and utility of the human plasma proteome. J Proteome Res. 2021;20(12):5241–5263. doi: 10.1021/acs.jproteome.1c00657
   PubMed Web of Science ®Google Scholar
• Moaddel R, Ubaida-Mohien C, Tanaka T, et al. Proteomics in aging research: a roadmap to clinical, translational research. Aging Cell. 2021;20(4):e13325. doi: 10.1111/acel.13325
   PubMed Web of Science ®Google Scholar
• Cheema AK, Li Y, Moulton J, et al. Identification of novel biomarkers for acute radiation injury using multiomics approach and nonhuman primate model. Int J Radiat Oncol Biol Phys. 2022;114:310–320. doi: 10.1016/j.ijrobp.2022.05.046
   PubMed Web of Science ®Google Scholar
• Carpenter AD, Li Y, Janocha BL, et al. Analysis of the proteomic profile in serum of irradiated nonhuman primates treated with Ex-Rad, a radiation medical countermeasure. J Proteome Res. 2023;22(4):1116–1126. doi: 10.1021/acs.jproteome.2c00458
   PubMed Web of Science ®Google Scholar
• Girgis M, Li Y, Ma J, et al. Comparative proteomic analysis of serum from nonhuman primates administered BIO 300: a promising radiation countermeasure. Sci Rep. 2020;10(1):19343. doi: 10.1038/s41598-020-76494-4
   PubMed Web of Science ®Google Scholar
• Aslam B, Basit M, Nisar MA, et al. Proteomics: technologies and their applications. J Chromatogr Sci. 2017;55(2):182–196. doi: 10.1093/chromsci/bmw167
   PubMed Web of Science ®Google Scholar
• Gygi SP, Rochon Y, Franza BR, et al. Correlation between protein and mRNA abundance in yeast. Mol Cell Biol. 1999;19(3):1720–1730. doi: 10.1128/MCB.19.3.1720
   PubMed Web of Science ®Google Scholar
• Kuster B, Schirle M, Mallick P, et al. Scoring proteomes with proteotypic peptide probes. Nat Rev Mol Cell Biol. 2005;6(7):577–583. doi: 10.1038/nrm1683
   PubMed Web of Science ®Google Scholar
• Domon B, Aebersold R. Mass spectrometry and protein analysis. Science. 2006;312(5771):212–217. doi: 10.1126/science.1124619
   PubMed Web of Science ®Google Scholar
• Zhu H, Snyder M. Protein arrays and microarrays. Curr Opin Chem Biol. 2001;5(1):40–45. doi: 10.1016/S1367-5931(00)00170-8
   PubMed Web of Science ®Google Scholar
• Gavin AC, Maeda K, Kuhner S. Recent advances in charting protein-protein interaction: mass spectrometry-based approaches. Curr Opin Biotechnol. 2011;22:42–49. doi: 10.1016/j.copbio.2010.09.007
   PubMed Web of Science ®Google Scholar
• Song YL, Johnson CB. Western blotting: methods and application. Methods Mol Biol. 2009;528:23–44.
   Google Scholar
• Hage DS, Anguizola JA, Bi C, et al. Pharmaceutical and biomedical applications of affinity chromatography: recent trends and developments. J Pharm Biomed Anal. 2012;69:93–105. doi: 10.1016/j.jpba.2012.01.004
   PubMed Web of Science ®Google Scholar
• Block H, Maertens B, Spriestersbach A, et al. Immobilized-metal affinity chromatography (IMAC): a review. Methods Enzymol. 2014;463:439–73. doi: 10.1016/S0076-6879(09)63027-5
   Google Scholar
• Voedisch B, Thie H. Size exclusion chromatography. In: Kontermann R Dübel S, editors. Antibody engineering. Berlin (Heildberg): Springer; 2010. p. 607–612. doi: 10.1007/978-3-642-01144-3_38
   Google Scholar
• Some D, Amartely H, Tsadok A, et al. Characterization of proteins by size-exclusion chromatography coupled to multi-angle light scattering (SEC-MALS). J Vis Exp. 2019;148(148):| e59615. doi: 10.3791/59615
   Google Scholar
• Jungbauer A, Hahn R. Ion-exchange chromatography. Methods Enzymol. 2009;463:349–371.
   PubMed Web of Science ®Google Scholar
• Abdulrahman A, Ghanem A. Recent advances in chromatographic purification of plasmid DNA for gene therapy and DNA vaccines: a review. Anal Chim Acta. 2018;1025:41–57. doi: 10.1016/j.aca.2018.04.001
   PubMed Web of Science ®Google Scholar
• Hayrapetyan H, Tran T, Tellez-Corrales E, et al. Enzyme-linked immunosorbent assay: types and applications. Methods Mol Biol. 2023;2612:1–17.
   PubMedGoogle Scholar
• Singh VK, Wise SY, Scott JR, et al. Radioprotective efficacy of delta-tocotrienol, a vitamin E isoform, is mediated through granulocyte colony-stimulating factor. Life Sci. 2014;98(2):113–122. doi: 10.1016/j.lfs.2014.01.065
   PubMed Web of Science ®Google Scholar
• Chowdhury F, Williams A, Johnson P. Validation and comparison of two multiplex technologies, Luminex and mesoscale discovery, for human cytokine profiling. J Immunol Methods. 2009;340:55–64. doi: 10.1016/j.jim.2008.10.002
   PubMed Web of Science ®Google Scholar
• Raffield LM, Dang H, Pratte KA, et al. Comparison of proteomic assessment methods in multiple cohort studies. Proteomics. 2020;20(12):e1900278. doi: 10.1002/pmic.201900278
   PubMed Web of Science ®Google Scholar
• Timms JF, Cramer R. Difference gel electrophoresis. Proteomics. 2008;8(23–24):4886–4897. doi: 10.1002/pmic.200800298
   PubMed Web of Science ®Google Scholar
• Ohlendieck K. Comparative DIGE proteomics. Methods Mol Biol. 2018;1664:17–24.
   PubMedGoogle Scholar
• Arentz G, Weiland F, Oehler MK, et al. State of the art of 2D DIGE. Proteomics Clin Appl. 2015;9(3–4):277–288. doi: 10.1002/prca.201400119
   PubMed Web of Science ®Google Scholar
• Michalski A, Cox J, Mann M. More than 100,000 detectable peptide species elute in single shotgun proteomics runs but the majority is inaccessible to data-dependent LC-MS/MS. J Proteome Res. 2011;10:1785–1793. doi: 10.1021/pr101060v
   PubMed Web of Science ®Google Scholar
• Bantscheff M, Schirle M, Sweetman G, et al. Quantitative mass spectrometry in proteomics: a critical review. Anal Bioanal Chem. 2007;389(4):1017–1031. doi: 10.1007/s00216-007-1486-6
   PubMed Web of Science ®Google Scholar
• Lundberg M, Thorsen SB, Assarsson E, et al. Multiplexed homogeneous proximity ligation assays for high-throughput protein biomarker research in serological material. Mol & Cell Proteomics. 2011;10(4):M110 004978. doi: 10.1074/mcp.M110.004978
   PubMed Web of Science ®Google Scholar
• Ong SE, Blagoev B, Kratchmarova I, et al. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics. 2002;1(5):376–386. doi: 10.1074/mcp.M200025-MCP200
   PubMed Web of Science ®Google Scholar
• Collins BC, Hunter CL, Liu Y, et al. Multi-laboratory assessment of reproducibility, qualitative and quantitative performance of SWATH-mass spectrometry. Nat Commun. 2017;8(1):291. doi: 10.1038/s41467-017-00249-5
   PubMed Web of Science ®Google Scholar
• Egertson JD, Kuehn A, Merrihew GE, et al. Multiplexed MS/MS for improved data-independent acquisition. Nat Methods. 2013;10(8):744–746. doi: 10.1038/nmeth.2528
   PubMed Web of Science ®Google Scholar
• Peterson AC, Russell JD, Bailey DJ, et al. Parallel reaction monitoring for high resolution and high mass accuracy quantitative, targeted proteomics. Mol & Cell Proteomics. 2012;11(11):1475–1488. doi: 10.1074/mcp.O112.020131
   PubMed Web of Science ®Google Scholar
• Specht H, Slavov N. Transformative opportunities for single-cell proteomics. J Proteome Res. 2018;17(8):2565–2571. doi: 10.1021/acs.jproteome.8b00257
   PubMed Web of Science ®Google Scholar
• Wang W, Zhou H, Lin H, et al. Quantification of proteins and metabolites by mass spectrometry without isotopic labeling or spiked standards. Anal Chem. 2003;75(18):4818–4826. doi: 10.1021/ac026468x
   PubMed Web of Science ®Google Scholar
• Gillet LC, Navarro P, Tate S, et al. Targeted data extraction of the MS/MS spectra generated by data-independent acquisition: a new concept for consistent and accurate proteome analysis. Mol & Cell Proteomics. 2012;11(6):O111 016717. doi: 10.1074/mcp.O111.016717
   PubMed Web of Science ®Google Scholar
• Liotta LA, Kohn EC, Petricoin EF. Clinical proteomics: personalized molecular medicine. JAMA. 2001;286(18):2211–2214. doi: 10.1001/jama.286.18.2211
   PubMed Web of Science ®Google Scholar
• Ramachandran N, Hainsworth E, Bhullar B, et al. Self-assembling protein microarrays. Science. 2004;305(5680):86–90. doi: 10.1126/science.1097639
   PubMed Web of Science ®Google Scholar
• Zhao L, Cong X, Zhai L, et al. Comparative evaluation of label-free quantification strategies. J Proteomics. 2020;215:103669. doi: 10.1016/j.jprot.2020.103669
   PubMed Web of Science ®Google Scholar
• Pappireddi N, Martin L, Wuhr M. A review on quantitative Multiplexed proteomics. Chembiochem. 2019;20(10):1210–1224. doi: 10.1002/cbic.201800650
   PubMed Web of Science ®Google Scholar
• Thompson A, Schafer J, Kuhn K, et al. Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS. Anal Chem. 2003;75(8):1895–1904. doi: 10.1021/ac0262560
   PubMed Web of Science ®Google Scholar
• Ross PL, Huang YN, Marchese JN, et al. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol & Cell Proteomics. 2004;3(12):1154–1169. doi: 10.1074/mcp.M400129-MCP200
   PubMed Web of Science ®Google Scholar
• Gygi SP, Rist B, Gerber SA, et al. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol. 1999;17(10):994–999. doi: 10.1038/13690
   PubMed Web of Science ®Google Scholar
• Deng J, Erdjument-Bromage H, Neubert TA. Quantitative comparison of proteomes using SILAC. Curr Protoc Protein Sci. 2019;95:e74. doi: 10.1002/cpps.74
   PubMedGoogle Scholar
• Lualdi M, Fasano M. Statistical analysis of proteomics data: a review on feature selection. J Proteomics. 2019;198:18–26. doi: 10.1016/j.jprot.2018.12.004
   PubMed Web of Science ®Google Scholar
• Vihinen M. Bioinformatics in proteomics. Biomol Eng. 2001;18(5):241–248. doi: 10.1016/S1389-0344(01)00099-5
   PubMedGoogle Scholar
• MacDougall A, Volynkin V, Saidi R, et al. UniRule: a unified rule resource for automatic annotation in the UniProt knowledgebase. Bioinformatics. 2021;36(22–23):5562. doi: 10.1093/bioinformatics/btaa663
   PubMed Web of Science ®Google Scholar
• Palomba A, Abbondio M, Fiorito G, et al. Comparative evaluation of MaxQuant and proteome discoverer MS1-based protein quantification tools. J Proteome Res. 2021;20(7):3497–3507. doi: 10.1021/acs.jproteome.1c00143
   PubMed Web of Science ®Google Scholar
• Perez-Riverol Y, Csordas A, Bai J, et al. The PRIDE database and related tools and resources in 2019: improving support for quantification data. Nucleic Acids Res. 2019;47:D442–D50. doi: 10.1093/nar/gky1106
   PubMed Web of Science ®Google Scholar
• MacLean B, Tomazela DM, Shulman N, et al. Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics. 2010;26(7):966–968. doi: 10.1093/bioinformatics/btq054
   PubMed Web of Science ®Google Scholar
• Mi H, Muruganujan A, Ebert D, et al. PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools. Nucleic Acids Res. 2019;47:D419–D26. doi: 10.1093/nar/gky1038
   PubMed Web of Science ®Google Scholar
• Ashburner M, Ball CA, Blake JA, et al. Gene ontology: tool for the unification of biology. The gene ontology Consortium. Nat Genet. 2000;25(1):25–29. doi: 10.1038/75556
   PubMed Web of Science ®Google Scholar
• Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44–57. doi: 10.1038/nprot.2008.211
   PubMed Web of Science ®Google Scholar
• Shakyawar SK, Mishra NK, Vellichirammal NN, et al. A review of radiation-induced alterations of multi-omic profiles, radiation injury biomarkers, and countermeasures. Radiat Res. 2023;199: doi: 10.1667/RADE-21-00187.1
   PubMed Web of Science ®Google Scholar
• Singh VK, Newman VL, Seed TM. Colony-stimulating factors for the treatment of the hematopoietic component of the acute radiation syndrome (H-ARS): a review. Cytokine. 2015;71(1):22–37. doi: 10.1016/j.cyto.2014.08.003
   PubMed Web of Science ®Google Scholar
• Singh VK, Yadav VS. Role of cytokines and growth factors in radioprotection. Exp Mol Pathol. 2005;78(2):156–169. doi: 10.1016/j.yexmp.2004.10.003
   PubMed Web of Science ®Google Scholar
• Ossetrova NI, Blakely WF, Nagy V, et al. Non-human primate total-body irradiation model with limited and full medical supportive care including filgrastim for biodosimetry and injury assessment. Radiat Prot Dosimetry. 2016;172(1–3):174–191. doi: 10.1093/rpd/ncw176
   PubMed Web of Science ®Google Scholar
• Singh VK, Fatanmi OO, Singh PK, et al. Role of radiation-induced granulocyte colony-stimulating factor in recovery from whole body gamma-irradiation. Cytokine. 2012;58(3):406–414. doi: 10.1016/j.cyto.2012.03.011
   PubMed Web of Science ®Google Scholar
• Singh VK, Seed TM. Radiation countermeasures for hematopoietic acute radiation syndrome: growth factors, cytokines and beyond. Int J Radiat Biol. 2021;97:1526–1547.
   PubMed Web of Science ®Google Scholar
• Farese AM, MacVittie TJ. Filgrastim for the treatment of hematopoietic acute radiation syndrome. Drugs Today (Barc). 2015;51:537–548. doi: 10.1358/dot.2015.51.9.2386730
   PubMed Web of Science ®Google Scholar
• Hankey KG, Farese AM, Blaauw EC, et al. Pegfilgrastim improves survival of lethally irradiated nonhuman primates. Radiat Res. 2015;183(6):643–655. doi: 10.1667/RR13940.1
   PubMed Web of Science ®Google Scholar
• Farese AM, Cohen MV, Katz BP, et al. Filgrastim improves survival in lethally irradiated nonhuman primates. Radiat Res. 2013;179(1):89–100. doi: 10.1667/RR3049.1
   PubMed Web of Science ®Google Scholar
• Zhong Y, Pouliot M, Downey AM, et al. Efficacy of delayed administration of sargramostim up to 120 hours post exposure in a nonhuman primate total body radiation model. Int J Radiat Biol. 2021;97:S100–S16. doi: 10.1080/09553002.2019.1673499
   PubMed Web of Science ®Google Scholar
• Wong K, Chang PY, Fielden M, et al. Pharmacodynamics of romiplostim alone and in combination with pegfilgrastim on acute radiation-induced thrombocytopenia and neutropenia in non-human primates. Int J Radiat Biol. 2020;96(1):155–166. doi: 10.1080/09553002.2019.1625488
   PubMed Web of Science ®Google Scholar
• Clayton NP, Khan-Malek RC, Dangler CA, et al. Sargramostim (rhu GM-CSF) improves survival of non-human primates with severe bone marrow suppression after acute, high-dose, whole-body irradiation. Radiat Res. 2021;195:191–199. doi: 10.1667/RADE-20-00131.1
   PubMed Web of Science ®Google Scholar
• Bunin DI, Javitz HS, Gahagen J, et al. Survival and hematologic benefits of romiplostim after acute radiation exposure supported FDA approval under the animal rule. Int J Radiat Oncol Biol Phys. 2023;117(3):705–717. in press. doi: 10.1016/j.ijrobp.2023.05.008
   PubMed Web of Science ®Google Scholar
• Shakhov AN, Singh VK, Bone F, et al. Prevention and mitigation of acute radiation syndrome in mice by synthetic lipopeptide agonists of Toll-like receptor 2 (TLR2). PLoS One. 2012;7(3):e33044. doi: 10.1371/journal.pone.0033044
   PubMed Web of Science ®Google Scholar
• Singh VK, Christensen J, Fatanmi OO, et al. Myeloid progenitors: a radiation countermeasure that is effective when initiated days after irradiation. Radiat Res. 2012;177(6):781–791. doi: 10.1667/RR2894.1
   PubMed Web of Science ®Google Scholar
• Singh VK, Ducey EJ, Fatanmi OO, et al. CBLB613: a TLR 2/6 agonist, natural lipopeptide of Mycoplasma arginini, as a novel radiation countermeasure. Radiat Res. 2012;177(5):628–642. doi: 10.1667/RR2657.1
   PubMed Web of Science ®Google Scholar
• Ossetrova NI, Stanton P, Krasnopolsky K, et al. Comparison of biodosimetry biomarkers for radiation dose and injury assessment after mixed-field (neutron and gamma) and pure gamma radiation in the mouse total-body irradiation model. Health Phys. 2018;115:743–759. doi: 10.1097/HP.0000000000000939
   PubMed Web of Science ®Google Scholar
• Ossetrova NI, Stanton P, Krasnopolsky K, et al. Biomarkers for radiation biodosimetry and injury assessment after mixed-field (neutron and gamma) radiation in the mouse total-body irradiation model. Health Phys. 2018;115:727–742. doi: 10.1097/HP.0000000000000938
   PubMed Web of Science ®Google Scholar
• Kiang JG, Smith JT, Hegge SR, et al. Circulating cytokine/chemokine concentrations respond to ionizing radiation doses but not radiation dose rates: granulocyte-colony stimulating factor and interleukin-18. Radiat Res. 2018;189(6):634–643. doi: 10.1667/RR14966.1
   PubMed Web of Science ®Google Scholar
• Xiao M, Bolduc DL, Li X, et al. Urine interleukin-18 (IL-18) as a biomarker of total-body irradiation: a preliminary study in nonhuman primates. Radiat Res. 2017;188(3):325–334. doi: 10.1667/RR14768.1
   PubMed Web of Science ®Google Scholar
• Gulani J, Koch A, Chappell MG, et al. Cercopithecine herpesvirus 9 (simian varicella virus) infection after total-body irradiation in a rhesus macaque (Macaca mulatta). Comp Med. 2016;66:150–153.
   PubMed Web of Science ®Google Scholar
• Ossetrova NI, Sandgren DJ, Blakely WF. Protein biomarkers for enhancement of radiation dose and injury assessment in nonhuman primate total-body irradiation model. Radiat Prot Dosimetry. 2014;159(1–4):61–76. doi: 10.1093/rpd/ncu165
   PubMed Web of Science ®Google Scholar
• Ossetrova NI, Condliffe DP, Ney PH, et al. Early-response biomarkers for assessment of radiation exposure in a mouse total-body irradiation model. Health Phys. 2014;106:772–786. doi: 10.1097/HP.0000000000000094
   PubMed Web of Science ®Google Scholar
• Blakely WF, Sandgren DJ, Nagy V, et al. Further biodosimetry investigations using murine partial-body irradiation model. Radiat Prot Dosimetry. 2014;159(1–4):46–51. doi: 10.1093/rpd/ncu127
   PubMed Web of Science ®Google Scholar
• Prasanna PG, Blakely WF, Bertho JM, et al. Synopsis of partial-body radiation diagnostic biomarkers and medical management of radiation injury workshop. Radiat Res. 2010;173:245–253. doi: 10.1667/RR1993.1
   PubMedGoogle Scholar
• Blakely WF, Ossetrova NI, Whitnall MH, et al. Multiple parameter radiation injury assessment using a nonhuman primate radiation model-biodosimetry applications. Health Phys. 2010;98:153–159. doi: 10.1097/HP.0b013e3181b0306d
   PubMed Web of Science ®Google Scholar
• Ossetrova NI, Blakely WF. Multiple blood-proteins approach for early-response exposure assessment using an in vivo murine radiation model. Int J Radiat Biol. 2009;85(10):837–850. doi: 10.3109/09553000903154799
   PubMed Web of Science ®Google Scholar
• Ha CT, Li X, Fu D, et al. Circulating IL-18 binding protein (IL-18BP) and IL-18 as dual biomarkers of total-body irradiation in mice. Radiat Res. 2016;185(4):375–383. doi: 10.1667/RR14238.1
   PubMed Web of Science ®Google Scholar
• Li X, Cui W, Hull L, et al. IL-18 binding protein (IL-18BP) as a novel radiation countermeasure after radiation exposure in mice. Sci Rep. 2020;10(1):18674. doi: 10.1038/s41598-020-75675-5
   PubMed Web of Science ®Google Scholar
• Ossetrova NI, Sandgren DJ, Gallego S, et al. Combined approach of hematological biomarkers and plasma protein SAA for improvement of radiation dose assessment triage in biodosimetry applications. Health Phys. 2010;98:204–208. doi: 10.1097/HP.0b013e3181abaabf
   PubMed Web of Science ®Google Scholar
• Ossetrova NI, Ney PH, Condliffe DP, et al. Acute radiation syndrome severity score system in mouse total-body irradiation model. Health Phys. 2016;111:134–144. doi: 10.1097/HP.0000000000000499
   PubMed Web of Science ®Google Scholar
• Bell BL, Vercellino J, Brodin NP, et al. Orthovoltage X-rays exhibit increased efficacy compared with γ-rays in preclinical irradiation. Cancer Res. 2022;82:2678–2691. doi: 10.1158/0008-5472.CAN-22-0656
   PubMed Web of Science ®Google Scholar
• Ha CT, Li XH, Fu D, et al. Circulating interleukin-18 as a biomarker of total-body radiation exposure in mice, minipigs, and nonhuman primates (NHP). PLoS One. 2014;9(10):e109249. doi: 10.1371/journal.pone.0109249
   PubMed Web of Science ®Google Scholar
• Singh VK, Fatanmi OO, Wise SY, et al. Determination of lethality curve for cobalt-60 gamma-radiation source in rhesus macaques using subject-based supportive care. Radiat Res. 2022;198:599–614. doi: 10.1667/RADE-22-00101.1
   PubMed Web of Science ®Google Scholar
• Singh VK, Kulkarni S, Fatanmi OO, et al. Radioprotective efficacy of gamma-tocotrienol in nonhuman primates. Radiat Res. 2016;185:285–298. doi: 10.1667/RR14127.1
   PubMed Web of Science ®Google Scholar
• Krivokrysenko VI, Shakhov AN, Singh VK, et al. Identification of granulocyte colony-stimulating factor and interleukin-6 as candidate biomarkers of CBLB502 efficacy as a medical radiation countermeasure. J Pharmacol Exp Ther. 2012;343:497–508. doi: 10.1124/jpet.112.196071
   PubMed Web of Science ®Google Scholar
• Krivokrysenko VI, Toshkov IA, Gleiberman AS, et al. The Toll-like receptor 5 agonist Entolimod mitigates lethal acute radiation syndrome in non-human primates. PLoS One. 2015;10:e0135388. doi: 10.1371/journal.pone.0135388
   PubMed Web of Science ®Google Scholar
• Singh VK, Carpenter AD, Janocha BL, et al. Radiosensitivity of rhesus nonhuman primates: consideration of sex, supportive care, body weight and age at time of exposure. Expert Opin Drug Discov. 2023;18:797–814. doi: 10.1080/17460441.2023.2205123
   PubMed Web of Science ®Google Scholar
• Cui W, Hankey KG, Zhang P, et al. Identifying circulating and lung tissue cytokines associated with thoracic irradiation and AEOL 10150 treatment in a nonhuman primate model. Radiat Res. 2020;194(1):81. doi: 10.1667/RR14310.1
   PubMed Web of Science ®Google Scholar
• Huang W, Yu J, Jones JW, et al. Proteomic evaluation of the acute radiation syndrome of the gastrointestinal tract in a murine total-body irradiation model. Health Phys. 2019;116:516–528. doi: 10.1097/HP.0000000000000951
   PubMed Web of Science ®Google Scholar
• Huang W, Yu J, Jones JW, et al. Acute proteomic changes in the lung after WTLI in a mouse model: identification of potential initiating events for delayed effects of acute radiation exposure. Health Phys. 2019;116:503–515. doi: 10.1097/HP.0000000000000956
   PubMed Web of Science ®Google Scholar
• Cheema AK, Byrum SD, Sharma NK, et al. Proteomic changes in mouse spleen after radiation-induced injury and its modulation by gamma-tocotrienol. Radiat Res. 2018;190(5):449–463. doi: 10.1667/RR15008.1
   PubMed Web of Science ®Google Scholar
• Rosen E, Fatanmi OO, Wise SY, et al. Tocol prophylaxis for total-body irradiation: a proteomic analysis in murine model. Health Phys. 2020;119:12–20. doi: 10.1097/HP.0000000000001221
   PubMed Web of Science ®Google Scholar
• Rosen E, Fatanmi OO, Wise SY, et al. Gamma-tocotrienol, a radiation countermeasure, reverses proteomic changes in serum following total-body gamma irradiation in mice. Sci Rep. 2022;12(1):3387. doi: 10.1038/s41598-022-07266-5
   PubMed Web of Science ®Google Scholar
• Rithidech KN, Honikel L, Rieger R, et al. Protein-expression profiles in mouse blood-plasma following acute whole-body exposure to (137)Cs gamma rays. Int J Radiat Biol. 2009;85:432–447. doi: 10.1080/09553000902820390
   PubMed Web of Science ®Google Scholar
• Sproull M, Shankavaram U, Camphausen K. Comparison of proteomic biodosimetry biomarkers across five different murine strains. Radiat Res. 2019;192(6):640–648. doi: 10.1667/RR15442.1
   PubMed Web of Science ®Google Scholar
• Zhang J, Han X, Zhao Y, et al. Mouse serum protects against total body irradiation-induced hematopoietic system injury by improving the systemic environment after radiation. Free Radic Biol Med. 2019;131:382–392. doi: 10.1016/j.freeradbiomed.2018.12.021
   PubMed Web of Science ®Google Scholar
• Yi L, Hu N, Mu H, et al. Identification of cofilin-1 and destrin as potential early-warning biomarkers for gamma radiation in mouse liver tissues. Health Phys. 2019;116:749–759. doi: 10.1097/HP.0000000000001012
   PubMed Web of Science ®Google Scholar
• Jin H, Jeon S, Kang GY, et al. Identification of radiation response genes and proteins from mouse pulmonary tissues after high-dose per fraction irradiation of limited lung volumes. Int J Radiat Biol. 2017;93(2):184–193. doi: 10.1080/09553002.2017.1235297
   PubMed Web of Science ®Google Scholar
• Kulkarni S, Koller A, Mani KM, et al. Identifying urinary and serum exosome biomarkers for radiation exposure using a data dependent acquisition and SWATH-MS combined workflow. Int J Radiat Oncol Biol Phys. 2016;96(3):566–577. doi: 10.1016/j.ijrobp.2016.06.008
   PubMed Web of Science ®Google Scholar
• Shukla S, Shankavaram UT, Nguyen P, et al. Radiation-induced alteration of the brain proteome: understanding the role of the sirtuin 2 deacetylase in a murine model. J Proteome Res. 2015;14(10):4104–4117. doi: 10.1021/acs.jproteome.5b00083
   PubMed Web of Science ®Google Scholar
• Lin RX, Zhao HB, Li CR, et al. Proteomic analysis of ionizing radiation-induced proteins at the subcellular level. J Proteome Res. 2009;8(1):390–399. doi: 10.1021/pr800699w
   PubMed Web of Science ®Google Scholar
• Lee Y, Pujol Canadell M, Shuryak I, et al. Candidate protein markers for radiation biodosimetry in the hematopoietically humanized mouse model. Sci Rep. 2018;8(1):13557. doi: 10.1038/s41598-018-31740-8
   PubMedGoogle Scholar
• Sun JL, Li S, Lu X, et al. Identification of the differentially expressed protein biomarkers in rat blood plasma in response to gamma irradiation. Int J Radiat Biol. 2020;96(6):748–758. doi: 10.1080/09553002.2020.1739775
   PubMed Web of Science ®Google Scholar
• Sharma M, Halligan BD, Wakim BT, et al. The urine proteome for radiation biodosimetry: effect of total body vs. local kidney irradiation. Health Phys. 2010;98:186–195. doi: 10.1097/HP.0b013e3181b17cbd
   PubMed Web of Science ®Google Scholar
• Sproull M, Nishita D, Chang P, et al. Comparison of proteomic expression profiles after radiation exposure across four different species. Radiat Res. 2022;197(4):315–323. doi: 10.1667/RADE-21-00182.1
   PubMed Web of Science ®Google Scholar
• Sproull M, Shankavaram U, Camphausen K. Novel murine biomarkers of radiation exposure using an aptamer-based proteomic technology. Front Pharmacol. 2021;12:633131. doi: 10.3389/fphar.2021.633131
   PubMed Web of Science ®Google Scholar
• Sproull M, Kawai T, Krauze A, et al. Prediction of total-body and partial-body exposures to radiation using plasma proteomic expression profiles. Radiat Res. 2022;198(6):573–581. doi: 10.1667/RADE-22-00074.1
   PubMed Web of Science ®Google Scholar
• Byrum SD, Burdine MS, Orr L, et al. Time- and radiation-dose dependent changes in the plasma proteome after total body irradiation of non-human primates: implications for biomarker selection. PLoS One. 2017;12(3):e0174771. doi: 10.1371/journal.pone.0174771
   PubMed Web of Science ®Google Scholar
• Byrum SD, Burdine MS, Orr L, et al. A quantitative proteomic analysis of urine from gamma-irradiated nonhuman primates. J Proteomics Bioinform. 2016;9:005. doi: 10.4172/jpb.S10-005
   PubMedGoogle Scholar
• Huang W, Yu J, Liu T, et al. Proteomics of non-human primate plasma after partial-body radiation with minimal bone marrow sparing. Health Phys. 2020;119:621–632. doi: 10.1097/HP.0000000000001350
   PubMed Web of Science ®Google Scholar
• Huang W, Yu J, Farese AM, et al. Acute proteomic changes in non-human primate kidney after partial-body radiation with minimal bone marrow sparing. Health Phys. 2021;121:345–351. doi: 10.1097/HP.0000000000001475
   PubMed Web of Science ®Google Scholar
• Huang W, Yu J, Liu T, et al. Acute proteomic changes in lung after radiation: toward identifying initiating events of delayed effects of acute radiation exposure in non-human primate after partial body irradiation with minimal bone marrow sparing. Health Phys. 2021;121:384–394. doi: 10.1097/HP.0000000000001476
   PubMed Web of Science ®Google Scholar
• Huang W, Yu J, Liu T, et al. Proteomic evaluation of the natural history of the acute radiation syndrome of the gastrointestinal tract in a non-human primate model of partial-body irradiation with minimal bone marrow sparing includes dysregulation of the retinoid pathway. Health Phys. 2020;119:604–620. doi: 10.1097/HP.0000000000001351
   PubMed Web of Science ®Google Scholar
• Pannkuk EL, Fornace AJ Jr., Laiakis EC. Metabolomic applications in radiation biodosimetry: exploring radiation effects through small molecules. Int J Radiat Biol. 2017;93:1151–1176.
   PubMed Web of Science ®Google Scholar
• Singh VK, Seed TM, Cheema AK. Metabolomics-based predictive biomarkers of radiation injury and countermeasure efficacy: Current status and future perspectives. Expert Rev Mol Diagn. 2021;21(7):641–654. doi: 10.1080/14737159.2021.1933448
   PubMed Web of Science ®Google Scholar
• Zalesak-Kravec S, Huang W, Wang P, et al. Multi-omic analysis of non-human primate heart after partial-body radiation with minimal bone marrow sparing. Health Phys. 2021;121:352–371. doi: 10.1097/HP.0000000000001478
   PubMed Web of Science ®Google Scholar
• Muller L, Huang W, Jones JW, et al. Complementary lipidomic, proteomic, and mass spectrometry imaging approach to the characterization of the acute effects of radiation in the non-human primate mesenteric lymph node after partial-body irradiation with minimal bone marrow sparing. Health Phys. 2021;121:372–383. doi: 10.1097/HP.0000000000001470
   PubMed Web of Science ®Google Scholar
• Kulkarni S, Singh PK, Ghosh SP, et al. Granulocyte colony-stimulating factor antibody abrogates radioprotective efficacy of gamma-tocotrienol, a promising radiation countermeasure. Cytokine. 2013;62(2):278–285. doi: 10.1016/j.cyto.2013.03.009
   PubMed Web of Science ®Google Scholar
• Singh VK, Hauer-Jensen M. Gamma-tocotrienol as a promising countermeasure for acute radiation syndrome: Current status. Int J Mol Sci. 2016;17:e663.
   PubMed Web of Science ®Google Scholar
• Singh PK, Wise SY, Ducey EJ, et al. Radioprotective efficacy of tocopherol succinate is mediated through granulocyte-colony stimulating factor. Cytokine. 2011;56(2):411–421. doi: 10.1016/j.cyto.2011.08.016
   PubMed Web of Science ®Google Scholar
• Singh VK, Brown DS, Kao TC. Alpha-tocopherol succinate protects mice from gamma-radiation by induction of granulocyte-colony stimulating factor. Int J Radiat Biol. 2010;86(1):12–21. doi: 10.3109/09553000903264515
   PubMed Web of Science ®Google Scholar
• Burdelya LG, Krivokrysenko VI, Tallant TC, et al. An agonist of Toll-like receptor 5 has radioprotective activity in mouse and primate models. Science. 2008;320:226–230. doi: 10.1126/science.1154986
   PubMed Web of Science ®Google Scholar
• Grace MB, Singh VK, Rhee JG, et al. 5-AED enhances survival of irradiated mice in a G-CSF-dependent manner, stimulates innate immune cell function, reduces radiation-induced DNA damage and induces genes that modulate cell cycle progression and apoptosis. J Radiat Res. 2012;53(6):840–853. doi: 10.1093/jrr/rrs060
   PubMed Web of Science ®Google Scholar
• Singh VK, Shafran RL, Inal CE, et al. Effects of whole-body gamma irradiation and 5-androstenediol administration on serum G-CSF. Immunopharmacol Immunotoxicol. 2005;27:521–534. doi: 10.1080/08923970500416707
   PubMed Web of Science ®Google Scholar
• Singh VK, Grace MB, Jacobsen KO, et al. Administration of 5-androstenediol to mice: pharmacokinetics and cytokine gene expression. Exp Mol Pathol. 2008;84:178–188. doi: 10.1016/j.yexmp.2007.12.001
   PubMed Web of Science ®Google Scholar
• Singh VK, Newman VL, Berg AN, et al. Animal models for acute radiation syndrome drug discovery. Expert Opin Drug Discov. 2015;10(5):497–517. doi: 10.1517/17460441.2015.1023290
   PubMed Web of Science ®Google Scholar
• Rittase WB, McCart EA, Muir JM, et al. Effects of captopril against radiation injuries in the Gottingen minipig model of hematopoietic-acute radiation syndrome. PLoS One. 2021;16:e0256208. doi: 10.1371/journal.pone.0256208
   PubMed Web of Science ®Google Scholar
• Singh VK, Seed TM. Entolimod as a radiation countermeasure for acute radiation syndrome. Drug Discov Today. 2021;26(1):17–30. doi: 10.1016/j.drudis.2020.10.003
   PubMed Web of Science ®Google Scholar
• Singh VK, Pollard HB. Patents for Toll-like receptor ligands as radiation countermeasures for acute radiation syndrome. Expert Opin Ther Pat. 2015;25(10):1085–1092. doi: 10.1517/13543776.2015.1064900
   PubMed Web of Science ®Google Scholar
• Singh VK, Hanlon BK, Santiago PT, et al. A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part III. Countermeasures under early stages of development along with ‘standard of care’ medicinal and procedures not requiring regulatory approval for use. Int J Radiat Biol. 2017;93(9):885–906. doi: 10.1080/09553002.2017.1332440
   PubMed Web of Science ®Google Scholar
• Singh VK, Seed TM. BIO 300: a promising radiation countermeasure under advanced development for acute radiation syndrome and the delayed effects of acute radiation exposure. Expert Opin Investig Drugs. 2020;29(5):429–441. doi: 10.1080/13543784.2020.1757648
   PubMed Web of Science ®Google Scholar
• Singh VK, Grace MB, Parekh VI, et al. Effects of genistein administration on cytokine induction in whole-body gamma irradiated mice. Int Immunopharmacol. 2009;9:1401–1410. doi: 10.1016/j.intimp.2009.08.012
   PubMed Web of Science ®Google Scholar
• Baliarsingh S, Beg ZH, Ahmad J. The therapeutic impacts of tocotrienols in type 2 diabetic patients with hyperlipidemia. Atherosclerosis. 2005;182(2):367–374. doi: 10.1016/j.atherosclerosis.2005.02.020
   PubMed Web of Science ®Google Scholar
• Qureshi AA, Burger WC, Peterson DM, et al. The structure of an inhibitor of cholesterol biosynthesis isolated from barley. J Biol Chem. 1986;261(23):10544–10550. doi: 10.1016/S0021-9258(18)67419-8
   PubMed Web of Science ®Google Scholar
• Singh VK, Seed TM. Development of gamma-tocotrienol as a radiation medical countermeasure for the acute radiation syndrome: Current status and future perspectives. Expert Opin Investig Drugs. 2023;32(1):25–35. doi: 10.1080/13543784.2023.2169127
   PubMed Web of Science ®Google Scholar
• Ghosh SP, Kulkarni S, Hieber K, et al. Gamma-tocotrienol, a tocol antioxidant as a potent radioprotector. Int J Radiat Biol. 2009;85(7):598–606. doi: 10.1080/09553000902985128.
   PubMed Web of Science ®Google Scholar
• Kulkarni SS, Cary LH, Gambles K, et al. Gamma-tocotrienol, a radiation prophylaxis agent, induces high levels of granulocyte colony-stimulating factor. Int Immunopharmacol. 2012;14(4):495–503. doi: 10.1016/j.intimp.2012.09.001
   PubMed Web of Science ®Google Scholar
• Singh VK, Wise SY, Fatanmi OO, et al. Progenitors mobilized by gamma-tocotrienol as an effective radiation countermeasure. PLoS One. 2014;9(11):e114078. doi: 10.1371/journal.pone.0114078
   PubMed Web of Science ®Google Scholar
• Singh VK, Fatanmi OO, Verma A, et al. Progenitor cell mobilization by gamma-tocotrienol: a promising radiation countermeasure. Health Phys. 2016;111:85–92. doi: 10.1097/HP.0000000000000458
   PubMed Web of Science ®Google Scholar
• Lee HT, Park SW, Kim M, et al. Interleukin-11 protects against renal ischemia and reperfusion injury. Am J Physiol Renal Physiol. 2012;303(8):F1216–24. doi: 10.1152/ajprenal.00220.2012
   PubMed Web of Science ®Google Scholar
• Kumar VP, Biswas S, Sharma NK, et al. Pegylated IL-11 (BBT-059): a novel radiation countermeasure for hematopoietic acute radiation syndrome. Health Phys. 2018;115:65–76. doi: 10.1097/HP.0000000000000841
   PubMed Web of Science ®Google Scholar
• Cwirla SE, Balasubramanian P, Duffin DJ, et al. Peptide agonist of the thrombopoietin receptor as potent as the natural cytokine. Science. 1997;276(5319):1696–1699. doi: 10.1126/science.276.5319.1696
   PubMed Web of Science ®Google Scholar
• Kumar VP, Holmes-Hampton GP, Biswas S, et al. Mitigation of total body irradiation-induced mortality and hematopoietic injury of mice by a thrombopoietin mimetic (JNJ-26366821). Sci Rep. 2022;12(1):3485. doi: 10.1038/s41598-022-07426-7
   PubMed Web of Science ®Google Scholar
• Ofir R. Prophylactic administration of placenta-derived PLX-R18 stromal cells mitigates H-ARS death and promotes BM and peripheral blood lineage recovery in a murine model. In: Radiation injury treatment network. Washington DC (USA); 2019.
   Google Scholar
• Kumar VP, Biswas S, Holmes-Hampton GP, et al. Pre-administration of PLX-R18 cells protects mice from radiation-induced hematopoietic failure and lethality. Genes (Basel). 2022;13(10):1756. doi: 10.3390/genes13101756
   PubMed Web of Science ®Google Scholar
• Singh VK, Brown DS, Kao TC. Tocopherol succinate: a promising radiation countermeasure. Int Immunopharmacol. 2009;9(12):1423–1430. doi: 10.1016/j.intimp.2009.08.020
   PubMed Web of Science ®Google Scholar
• Singh VK, Parekh VI, Brown DS, et al. Tocopherol succinate: modulation of antioxidant enzymes and oncogene expression, and hematopoietic recovery. Int J Radiat Oncol Biol Phys. 2011;79:571–578. doi: 10.1016/j.ijrobp.2010.08.019
   PubMed Web of Science ®Google Scholar
• Singh VK, Singh PK, Wise SY, et al. Radioprotective properties of tocopherol succinate against ionizing radiation in mice. J Radiat Res. 2013;54(2):210–220. doi: 10.1093/jrr/rrs088
   PubMed Web of Science ®Google Scholar
• Singh VK, Romaine PL, Newman VL, et al. Tocols induce G-CSF and mobilise progenitors that mitigate radiation injury. Radiat Prot Dosimetry. 2014;162(1–2):83–87. doi: 10.1093/rpd/ncu223
   PubMed Web of Science ®Google Scholar
• Barshishat-Kupper M, Mungunsukh O, Tipton AJ, et al. Captopril modulates hypoxia-inducible factors and erythropoietin responses in a murine model of total body irradiation. Exp Hematol. 2011;39(3):293–304. doi: 10.1016/j.exphem.2010.12.002
   PubMed Web of Science ®Google Scholar
• Orrell RW. AEOL-10150 (aeolus). Curr Opin Invest Drugs. 2006;7(1):70–80.
   PubMedGoogle Scholar
• Singh VK, Olabisi AO. Nonhuman primates as models for the discovery and development of radiation countermeasures. Expert Opin Drug Discov. 2017;12:695–709.
   PubMed Web of Science ®Google Scholar
• U.S. Food and Drug Administration. Animal Rule information. 2022. [cited 2022 Oct 20]. Available from: http://www.fda.gov/EmergencyPreparedness/Counterterrorism/MedicalCountermeasures/MCMRegulatoryScience/ucm391604.htm
   Google Scholar
• Singh VK, Beattie LA, Seed TM. Vitamin E: tocopherols and tocotrienols as potential radiation countermeasures. J Radiat Res. 2013;54:973–988. doi: 10.1093/jrr/rrt048
   PubMed Web of Science ®Google Scholar
• Bajaj S, Alam SI, Ahmad B, et al. Combination of podophyllotoxin and rutin modulate radiation induced alterations of jejunal proteome in mice. Int J Radiat Biol. 2020;96(7):1–39. doi: 10.1080/09553002.2020.1741721
   PubMed Web of Science ®Google Scholar
• Wang Q, Wang Y, Du L, et al. Quantitative proteomic analysis of the effects of melatonin treatment for mice suffered from small intestinal damage induced by gamma-ray radiation. Int J Radiat Biol. 2021;97:1206–1216. doi: 10.1080/09553002.2021.1956006
   PubMed Web of Science ®Google Scholar
• Singh VK, Garcia M, Seed TM. A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part II. Countermeasures for limited indications, internalized radionuclides, emesis, late effects, and agents demonstrating efficacy in large animals with or without FDA IND status. Int J Radiat Biol. 2017;93(9):870–884. doi: 10.1080/09553002.2017.1338782
   PubMed Web of Science ®Google Scholar
• Singh VK, Newman VL, Romaine PL, et al. Radiation countermeasure agents: an update (2011 - 2014). Expert Opin Ther Pat. 2014;24:1229–1255. doi: 10.1517/13543776.2014.964684
   PubMed Web of Science ®Google Scholar
• Kang AD, Cosenza SC, Bonagura M, et al. ON01210.Na (Ex-RAD(R)) mitigates radiation damage through activation of the AKT pathway. PLoS One. 2013;8:e58355. doi: 10.1371/journal.pone.0058355
   PubMed Web of Science ®Google Scholar
• Suman S, Datta K, Doiron K, et al. Radioprotective effects of on 01210.Na upon oral administration. J Radiat Res. 2012;53:368–376. doi: 10.1269/jrr.11191
   PubMed Web of Science ®Google Scholar
• Suman S, Maniar M, Fornace AJ Jr., et al. Administration of on 01210.Na after exposure to ionizing radiation protects bone marrow cells by attenuating DNA damage response. Radiat Oncol. 2012;7:6. doi: 10.1186/1748-717X-7-6
   PubMed Web of Science ®Google Scholar
• Singh VK, Fatanmi OO, Wise SY, et al. A novel oral formulation of BIO 300 confers prophylactic radioprotection from acute radiation syndrome in mice. Int J Radiat Biol. 2022;98(5):958–967. doi: 10.1080/09553002.2021.1981556
   PubMed Web of Science ®Google Scholar
• Singh VK, Serebrenik AA, Fatanmi OO, et al. The radioprotectant, BIO 300, protects the lungs from total-body irradiation injury in C57L/J mice. Radiat Res. 2023;199(3):294–300. doi: 10.1667/RADE-22-00142.1
   PubMed Web of Science ®Google Scholar
• Landauer MR, Srinivasan V, Seed TM. Genistein treatment protects mice from ionizing radiation injury. J Appl Toxicol. 2003;23(6):379–385. doi: 10.1002/jat.904
   PubMed Web of Science ®Google Scholar
• Davis TA, Clarke TK, Mog SR, et al. Subcutaneous administration of genistein prior to lethal irradiation supports multilineage, hematopoietic progenitor cell recovery and survival. Int J Radiat Biol. 2007;83(3):141–151. doi: 10.1080/09553000601132642
   PubMed Web of Science ®Google Scholar
• Li Y, Girgis M, Jayatilake M, et al. Pharmacokinetic and metabolomic studies with a BIO 300 oral powder formulation in nonhuman primates. Sci Rep. 2022;12(1):13475. doi: 10.1038/s41598-022-17807-7
   PubMed Web of Science ®Google Scholar
• Cheema AK, Mehta KY, Santiago PT, et al. Pharmacokinetic and metabolomic studies with BIO 300, a nanosuspension of genistein, in a nonhuman primate model. Int J Mol Sci. 2019;20:1231. doi: 10.3390/ijms20051231.
   PubMed Web of Science ®Google Scholar
• Laiakis EC, Pinheiro M, Nguyen T, et al. Quantitative proteomic analytic approaches to identify metabolic changes in the medial prefrontal cortex of rats exposed to space radiation. Front Physiol. 2022;13:971282. doi: 10.3389/fphys.2022.971282
   PubMed Web of Science ®Google Scholar
• Mo W, Xu W, Hong M, et al. Proteomic and miRNA profiling of radon-induced skin damage in mice: FASN regulated by miRnas. J Radiat Res. 2022;63(5):706–718. doi: 10.1093/jrr/rrac037
   PubMed Web of Science ®Google Scholar
• Langen B, Vorontsov E, Spetz J, et al. Age and sex effects across the blood proteome after ionizing radiation exposure can bias biomarker screening and risk assessment. Sci Rep. 2022;12(1):7000. doi: 10.1038/s41598-022-10271-3
   PubMed Web of Science ®Google Scholar
• Rithidech KN, Tungjai M, Jangiam W, et al. Proteomic profiling of hematopoietic stem/progenitor cells after a whole body exposure of CBA/CaJ mice to titanium ((48)Ti) ions. Proteomes. 2015;3:132–159. doi: 10.3390/proteomes3030132
   PubMed Web of Science ®Google Scholar
• Li H, He Y, Di C, et al. Comparative analysis of the serum proteome for biomarker discovery to reveal hepatotoxicity induced by iron ion radiation in mice. Life Sci. 2016;167:57–66. doi: 10.1016/j.lfs.2016.10.029
   PubMed Web of Science ®Google Scholar
• Biron DG, Loxdale HD, Ponton F, et al. Population proteomics: an emerging discipline to study metapopulation ecology. Proteomics. 2006;6(6):1712–1715. doi: 10.1002/pmic.200500423
   PubMed Web of Science ®Google Scholar
• Nedelkov D, Kiernan UA, Niederkofler EE, et al. Population proteomics: the concept, attributes, and potential for cancer biomarker research. Mol & Cell Proteomics. 2006;5(10):1811–1818. doi: 10.1074/mcp.R600006-MCP200
   PubMed Web of Science ®Google Scholar
• Bian Y, Gao C, Kuster B. On the potential of micro-flow LC-MS/MS in proteomics. Expert Rev Proteomics. 2022;19(3):153–164. doi: 10.1080/14789450.2022.2134780
   PubMed Web of Science ®Google Scholar
• Lenco J, Vajrychova M, Pimkova K, et al. Conventional-flow liquid chromatography-mass spectrometry for exploratory bottom-up proteomic analyses. Anal Chem. 2018;90:5381–5389. doi: 10.1021/acs.analchem.8b00525
   PubMed Web of Science ®Google Scholar
• Pannkuk EL, Laiakis EC, Singh VK, et al. Lipidomic signatures of nonhuman primates with radiation-induced hematopoietic syndrome. Sci Rep. 2017;7:9777.
   PubMed Web of Science ®Google Scholar
• Pannkuk EL, Laiakis EC, Fornace AJ Jr., et al. A metabolomic serum signature from nonhuman primates treated with a radiation countermeasure, gamma-tocotrienol, and exposed to ionizing radiation. Health Phys. 2018;115:3–11. doi: 10.1097/HP.0000000000000776
   PubMed Web of Science ®Google Scholar
• Coy SL, Krylov EV, Schneider BB, et al. Detection of radiation-exposure biomarkers by differential mobility prefiltered mass spectrometry (DMS-MS). Int J Mass Spectrom. 2010;291:108–117. doi: 10.1016/j.ijms.2010.01.013
   PubMed Web of Science ®Google Scholar
• Johnson CH, Patterson AD, Krausz KW, et al. Radiation metabolomics. 5. Identification of urinary biomarkers of ionizing radiation exposure in nonhuman primates by mass spectrometry-based metabolomics. Radiat Res. 2012;178(4):328–340. doi: 10.1667/RR2950.1
   PubMed Web of Science ®Google Scholar
• Li HH, Tyburski JB, Wang YW, et al. Modulation of fatty acid and bile acid metabolism by peroxisome proliferator-activated receptor alpha protects against alcoholic liver disease. Alcohol Clin Exp Res. 2014;38:1520–1531. doi: 10.1111/acer.12424
   PubMed Web of Science ®Google Scholar
• Johnson CH, Manna SK, Krausz KW, et al. Global metabolomics reveals urinary biomarkers of breast cancer in a mcf-7 xenograft mouse model. Metabolites. 2013;3(3):658–672. doi: 10.3390/metabo3030658
   PubMedGoogle Scholar
• Wang C, Yang J, Nie J. Plasma phospholipid metabolic profiling and biomarkers of rats following radiation exposure based on liquid chromatography-mass spectrometry technique. Biomed Chromatogr. 2009;23(10):1079–1085. doi: 10.1002/bmc.1226
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhou X, Li C, et al. Assessment of early triage for acute radiation injury in rat model based on urinary amino acid target analysis. Mol Biosyst. 2014;10(6):1441–1449. doi: 10.1039/C3MB70526A
   PubMedGoogle Scholar
• Liu H, Wang Z, Zhang X, et al. Selection of candidate radiation biomarkers in the serum of rats exposed to gamma-rays by GC/TOFMS-based metabolomics. Radiat Prot Dosimetry. 2013;154(1):9–17. doi: 10.1093/rpd/ncs138
   PubMed Web of Science ®Google Scholar
• Golla S, Golla JP, Krausz KW, et al. Metabolomic analysis of mice exposed to gamma radiation reveals a systemic understanding of total-body exposure. Radiat Res. 2017;187(5):612–629. doi: 10.1667/RR14592.1
   PubMed Web of Science ®Google Scholar
• Coy SL, Cheema AK, Tyburski JB, et al. Radiation metabolomics and its potential in biodosimetry. Int J Radiat Biol. 2011;87(8):802–823. doi: 10.3109/09553002.2011.556177
   PubMed Web of Science ®Google Scholar
• Tyburski JB, Patterson AD, Krausz KW, et al. Radiation metabolomics. 2. Dose- and time-dependent urinary excretion of deaminated purines and pyrimidines after sublethal gamma-radiation exposure in mice. Radiat Res. 2009;172(1):42–57. doi: 10.1667/RR1703.1
   PubMed Web of Science ®Google Scholar
• Mak TD, Tyburski JB, Krausz KW, et al. Exposure to ionizing radiation reveals global dose- and time-dependent changes in the urinary metabolome of rat. Metabolomics. 2015;11(5):1082–1094. doi: 10.1007/s11306-014-0765-4
   PubMed Web of Science ®Google Scholar
• Dissmore T, DeMarco AG, Jayatilake M, et al. Longitudinal metabolic alterations in plasma of rats exposed to low doses of high linear energy transfer radiation. J Environ Sci Health C Toxicol Carcinog. 2021;39:219–233. doi: 10.1080/26896583.2020.1865027
   PubMedGoogle Scholar
• Cheema AK, Mehta KY, Fatanmi OO, et al. A metabolomic and lipidomic serum signature from nonhuman primates administered with a promising radiation countermeasure, gamma-tocotrienol. Int J Mol Sci. 2018;19:79. doi: 10.3390/ijms19010079
   Web of Science ®Google Scholar